A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

NCT02696798 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondyloarthritis

Interventions

DRUG: Ixekizumab
DRUG: Placebo

Sponsor

Eli Lilly and Company